MedPath

Evaluation of the Impact of DiGAs in Patients with Type 2 Diabetes mellitus in daily practice

Not Applicable
Conditions
E11
Type 2 diabetes mellitus
Registration Number
DRKS00031271
Lead Sponsor
niversitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Medizinische Klinik III, Abteilung Prävention und Versorgung des Diabetes
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
82
Inclusion Criteria

?Patients = 18 years old
?Type 2 diabetes patients benefiting from improved self-management
?Enrolled in the Disease Management Program (DMP) for type 2 diabetes diabetes in Germany for at least the last 6 months
?Patients using/willing to use a Diabetes DiGA as part of their diabetes management
?HbA1c at baseline = 6.5 % and = 11.0 %
?Patients with internet access and a computer and/or smartphone compatible with the Diabetes DiGA
?Digital literacy to use a smartphone adequately and willing to use it for their diabetes self-management
?Sufficient understanding of user interface (UI) of the Diabetes DiGA
?Participants willing and able to comply with all scheduled visits, laboratory tests, lifestyle considerations and other study procedures
?Participants capable of giving personal informed consent

Exclusion Criteria

• Patients using other Apps for their diabetes management
• Patients who have been using a Diabetes DiGA in the past twelve months
•Patients with impairments – including mental or psychic impairments – or conditions which, in the opinion of the investigator, would seriously compromise the integrity of the study
• Patients under 18 years of age
• Patients participating in a weight loss program in the last 6 months
• Patients who are pregnant or breastfeeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath